-F Pierconti Researcher Activity Profile

Research Author Detailed Information 

F Pierconti Publication Rate By Year

F Pierconti has published 6 paper(s) in 2007, 3 paper(s) in 2008, for a total of 9 research publications in total.

F F Pierconti Author Information

LAST NAME: pierconti

FIRST NAME: F

INITIALS: f

AFFILIATION:

Papers

F Pierconti's Publication Record

1. Meckel's diverticulum findings on Tc-99m red blood cell scintigraphy in a bleeding leukemic patient confirmed by Tc-99m pertechnetate scintigraphy. Year Published: 2007
Department of General Surgery, Catholic University of Rome, Rome, Italy.
2. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Year Published: 2007
Istituto di Ematologia e di Anatomia Patologica, Universita' Cattolica S. Cuore, Rome, Italy. stefan.hohaus@rm.unicatt.it
3. Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. Year Published: 2007
Department of Internal Medicine, Catholic University of Sacred Heart, Roma, Italy.
4. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma. Year Published: 2007
Istituto di Ematologia e di Anatomia Patologica, Universita' Cattolica S. Cuore, Rome, Italy. stefan.hohaus@rm.unicatt.it
5. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. Year Published: 2007
Institute of Pathological Anatomy, Catholic University of Rome, School of Medicine, Largo Francesco Vito 1, 00168 Rome, Italy. labpatmol@rm.unicatt.it <labpatmol@rm.unicatt.it>
6. Meckel's diverticulum findings on Tc-99m red blood cell scintigraphy in a bleeding leukemic patient confirmed by Tc-99m pertechnetate scintigraphy. Year Published: 2007
Department of General Surgery, Catholic University of Rome, Rome, Italy.
7. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. Year Published: 2008
Institute of Neurobiology and Molecular Medicine, CNR, Rome, Italy. marialaura.falchetti@inmm.cnr.it
8. Phosphorylated STAT5 Represents a New Possible Prognostic Marker in Hodgkin Lymphoma. Year Published: 2008
The Departments of Pathology, Catholic University of Rome, Rome, Italy.
9. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. Year Published: 2008
Institute of Neurobiology and Molecular Medicine, CNR, Rome, Italy. marialaura.falchetti@inmm.cnr.it